How big is the Global Vascular Embolization Market?

The Global Vascular Embolization Market size is expected to reach USD 1.94 billion in 2024 and grow at a CAGR of 7.26% to reach USD 2.75 billion by 2029. Read More

What is the current Global Vascular Embolization Market size?

In 2024, the Global Vascular Embolization Market size is expected to reach USD 1.94 billion. Read More

Who are the key players in Global Vascular Embolization Market?

Medtronic Plc, Cook Medical, Stryker Corporation, Boston Scientific Corporation and Abbott Laboratories are the major companies operating in the Global Vascular Embolization Market. Read More

Which is the fastest growing region in Global Vascular Embolization Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Vascular Embolization Market?

In 2024, the North America accounts for the largest market share in Global Vascular Embolization Market. Read More

What years does this Global Vascular Embolization Market cover, and what was the market size in 2023?

In 2023, the Global Vascular Embolization Market size was estimated at USD 1.81 billion. The report covers the Global Vascular Embolization Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Vascular Embolization Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Vascular Embolization Market Share

Statistics for the 2023 & 2024 Global Vascular Embolization market share, created by Mordor Intelligence™ Industry Reports. Global Vascular Embolization share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Vascular Embolization Industry

The vascular embolization market is highly competitive and consists of several major players. Some of the companies that are currently dominating the market are Medtronic PLC, Cook Medical, Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, Johnson and Johnson (CERENOVUS), Merit Medical Systems Inc., Penumbra Inc., Terumo Corporation, and Shape Memory Medical Inc. The major players have used various strategies such as expansions, new product launches, and acquisitions to increase their footprints in this market. For instance, in October 2020, Johnson and Johnson launched NIMBUS to remove tough clots and enable revascularization for patients with acute ischaemic stroke in Europe.